Physicochemical Properties
Molecular Formula | C24H36D4O3 |
Molecular Weight | 380.60 |
Exact Mass | 380.323 |
CAS # | 83701-16-0 |
Related CAS # | Lithocholic acid;434-13-9 |
PubChem CID | 16217405 |
Appearance | White to off-white solid powder |
Density | 1.085 g/cm3 |
Boiling Point | 510.992ºC at 760 mmHg |
Melting Point | 184-186ºC(lit.) |
Flash Point | 276.926ºC |
LogP | 5.507 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Heavy Atom Count | 27 |
Complexity | 574 |
Defined Atom Stereocenter Count | 9 |
SMILES | [2H]C1(C[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC[C@@H]2C([C@@H]1O)([2H])[2H])CC[C@@H]4[C@H](C)CCC(=O)O)C)C)[2H] |
InChi Key | SMEROWZSTRWXGI-POXZWENPSA-N |
InChi Code | InChI=1S/C24H40O3/c1-15(4-9-22(26)27)19-7-8-20-18-6-5-16-14-17(25)10-12-23(16,2)21(18)11-13-24(19,20)3/h15-21,25H,4-14H2,1-3H3,(H,26,27)/t15-,16-,17-,18+,19-,20+,21+,23+,24-/m1/s1/i10D2,14D2 |
Chemical Name | (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-2,2,4,4-tetradeuterio-3-hydroxy-10,13-dimethyl-3,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
ln Vitro | Lithocholic acid is a secondary bile acid that is toxic[1]. |
References |
[1]. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A. 2001;98(6):3369-3374. |
Additional Infomation | Lithocholic acid-2,2,4,4-d4 is a deuterated compound and a lithocholic acid. |
Solubility Data
Solubility (In Vitro) | DMSO : 50 mg/mL (131.37 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 5 mg/mL (13.14 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 5 mg/mL (13.14 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.6274 mL | 13.1372 mL | 26.2743 mL | |
5 mM | 0.5255 mL | 2.6274 mL | 5.2549 mL | |
10 mM | 0.2627 mL | 1.3137 mL | 2.6274 mL |